The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the ...

The range of autoimmune diseases treatable with chimeric antigen receptor (CAR) T-cell therapy could be much broader than ...

For decades, scientists have puzzled over why smoking makes Crohn’s disease worse but seems to protect people from ulcerative ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

You and your doctor already have a variety of treatment options available for ulcerative colitis (UC), but science marches on, with the pharmaceutical industry close behind. Dozens of novel therapies ...

Patients with active ulcerative colitis may be able to reduce symptoms and achieve remission by taking a plant-based treatment combining the herbal compounds curcumin and qingdai, preliminary results ...

A naturally sourced treatment for ulcerative colitis (UC) demonstrates significant benefits for patients failing pharmaceutical treatment, according to results of a clinical trial presented at the ...

With ulcerative colitis (UC), it may feel like each day presents a new hurdle. You can get your symptoms under control and keep them in remission with treatment, yet because of the somewhat ...

What Is Proctitis and How Does It Compare to UC? Proctitis is inflammation of the rectum, the last part of the large intestine that connects the colon to the anus. Ulcerative colitis (UC) is a type of ...

The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately to severely ...

Tremfya is now the first and only fully subcutaneous IL-23 inhibitor approved to treat both ulcerative colitis and Crohn’s ...